These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 1720452

  • 1. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.
    Ortega JA, Krailo MD, Haas JE, King DR, Ablin AR, Quinn JJ, Feusner J, Campbell JR, Lloyd DA, Cherlow J.
    J Clin Oncol; 1991 Dec; 9(12):2167-76. PubMed ID: 1720452
    [Abstract] [Full Text] [Related]

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Dec; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
    Katzenstein HM, London WB, Douglass EC, Reynolds M, Plaschkes J, Finegold MJ, Bowman LC.
    J Clin Oncol; 2002 Aug 15; 20(16):3438-44. PubMed ID: 12177104
    [Abstract] [Full Text] [Related]

  • 5. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    Cancer; 2003 Apr 15; 97(8):2006-12. PubMed ID: 12673731
    [Abstract] [Full Text] [Related]

  • 6. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, Childs M, Pariente D, Laithier V, Otte JB, Branchereau S, Aronson D, Rangaswami A, Ronghe M, Casanova M, Sullivan M, Morland B, Czauderna P, Perilongo G, International Childhood Liver Tumours Strategy Group (SIOPEL).
    Lancet Oncol; 2013 Aug 15; 14(9):834-42. PubMed ID: 23831416
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
    Pritchard J, Brown J, Shafford E, Perilongo G, Brock P, Dicks-Mireaux C, Keeling J, Phillips A, Vos A, Plaschkes J.
    J Clin Oncol; 2000 Nov 15; 18(22):3819-28. PubMed ID: 11078495
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    J Clin Oncol; 2002 Jun 15; 20(12):2789-97. PubMed ID: 12065555
    [Abstract] [Full Text] [Related]

  • 9. Adriamycin and cis-platinum administered by continuous infusion preoperatively in hepatoblastoma unresectable at presentation.
    Langevin AM, Pierro A, Liu P, Filler RM, Greenberg ML.
    Med Pediatr Oncol; 1990 Jun 15; 18(3):181-4. PubMed ID: 1691816
    [Abstract] [Full Text] [Related]

  • 10. [Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH].
    von Schweinitz D, Bürger D, Weinel P, Mildenberger H.
    Klin Padiatr; 1992 Jun 15; 204(4):214-20. PubMed ID: 1381454
    [Abstract] [Full Text] [Related]

  • 11. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
    von Schweinitz D, Byrd DJ, Hecker H, Weinel P, Bode U, Bürger D, Erttmann R, Harms D, Mildenberger H.
    Eur J Cancer; 1997 Jul 15; 33(8):1243-9. PubMed ID: 9301450
    [Abstract] [Full Text] [Related]

  • 12. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
    Lee J, Park JO, Kim WS, Park SH, Park KW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Joh J, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K.
    Cancer Chemother Pharmacol; 2004 Nov 15; 54(5):385-90. PubMed ID: 15248028
    [Abstract] [Full Text] [Related]

  • 13. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
    Casanova M, Massimino M, Ferrari A, Spreafico F, Piva L, Coppa J, Luksch R, Cefalo G, Terenziani M, Polastri D, Bellani FF, Mazzaferro V.
    Pediatr Hematol Oncol; 2005 Nov 15; 22(3):189-98. PubMed ID: 16020101
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study.
    Douglass EC, Reynolds M, Finegold M, Cantor AB, Glicksman A.
    J Clin Oncol; 1993 Jan 15; 11(1):96-9. PubMed ID: 8380296
    [Abstract] [Full Text] [Related]

  • 15. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
    Ajani JA, Mayer RJ, Ota DM, Steele GD, Evans D, Roh M, Sugarbaker DJ, Dumas P, Gray C, Vena DA.
    J Natl Cancer Inst; 1993 Nov 17; 85(22):1839-44. PubMed ID: 8230264
    [Abstract] [Full Text] [Related]

  • 16. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.
    Leung TW, Patt YZ, Lau WY, Ho SK, Yu SC, Chan AT, Mok TS, Yeo W, Liew CT, Leung NW, Tang AM, Johnson PJ.
    Clin Cancer Res; 1999 Jul 17; 5(7):1676-81. PubMed ID: 10430068
    [Abstract] [Full Text] [Related]

  • 17. The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy.
    King DR, Ortega J, Campbell J, Haas J, Ablin A, Lloyd D, Newman K, Quinn J, Krailo M, Feusner J.
    J Pediatr Surg; 1991 Sep 17; 26(9):1074-80; discussion 1080-1. PubMed ID: 1658289
    [Abstract] [Full Text] [Related]

  • 18. The effect of chemotherapy on hepatoblastoma.
    Forouhar FA, Quinn JJ, Cooke R, Foster JH.
    Arch Pathol Lab Med; 1984 Apr 17; 108(4):311-4. PubMed ID: 6322723
    [Abstract] [Full Text] [Related]

  • 19. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
    Van Tornout JM, Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA.
    J Clin Oncol; 1997 Mar 17; 15(3):1190-7. PubMed ID: 9060563
    [Abstract] [Full Text] [Related]

  • 20. Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.
    Perilongo G, Brown J, Shafford E, Brock P, De Camargo B, Keeling JW, Vos A, Philips A, Pritchard J, Plaschkes J.
    Cancer; 2000 Oct 15; 89(8):1845-53. PubMed ID: 11042582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.